MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3904/kjim.2016.31.1.89

Медицинская библиотека · The Korean journal of internal medicine · 2015

Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma.

Lee Hwa Young, Rhee Chin Kook, Kang Ji Young, Park Chan Kwon, Lee Sook Young, Kwon Soon Suk, Kim Young Kyoon, Yoon Hyoung Kyu

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND/AIMS: Asthma is characterized by airway hyperresponsiveness, inflammation, and remodeling. Peroxisome proliferator-activated receptors have been reported to regulate inflammatory responses in many cells. In this study, we examined the effects of intranasal rosiglitazone on airway remodeling in a chronic asthma model.

METHODS

We developed a mouse model of airway remodeling, including smooth muscle thickening, in which ovalbumin (OVA)-sensitized mice were repeatedly exposed to intranasal OVA administration twice per week for 3 months. Mice were treated intranasally with rosiglitazone with or without an antagonist during OVA challenge. We determined airway inflammation and the degree of airway remodeling by smooth muscle actin area and collagen deposition.

RESULTS

Mice chronically exposed to OVA developed sustained eosinophilic airway inflammation, compared with control mice. Additionally, the mice developed features of airway remodeling, including thickening of the peribronchial smooth muscle layer. Administration of rosiglitazone intranasally inhibited the eosinophilic inflammation significantly, and, importantly, airway smooth muscle remodeling in mice chronically exposed to OVA. Expression of Toll-like receptor (TLR)-4 and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) was increased in the OVA group and decreased in the rosiglitazone group. Co-treatment with GW9660 (a rosiglitazone antagonist) and rosiglitazone increased the expression of TLR-4 and NF-κB.

CONCLUSIONS

These results suggest that intranasal administration of rosiglitazone can prevent not only air way inf lammation but also air way remodeling associated with chronic allergen challenge. This beneficial effect is mediated by inhibition of TLR-4 and NF-κB pathways.

Для цитирования: Lee Hwa Young, Rhee Chin Kook, Kang Ji Young, Park Chan Kwon, Lee Sook Young, Kwon Soon Suk, Kim Young Kyoon, Yoon Hyoung Kyu. Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma.. The Korean journal of internal medicine. 2015. DOI: 10.3904/kjim.2016.31.1.89.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.